U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164924) titled 'Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility' on March 06.
Brief Summary: CONTEXT A desire for pregnancy is common in young patients with multiple sclerosis (MS). The impact of MS on women fertility is debated, and the impact of disease-modifying therapies (DMTs) on fertility is not well known. Antimullerian hormone (AMH) is a representative biomarker of ovarian reserve that can be used to explore this issue.
OBJECTIVES To examine the impact of MS activity and related DMTs on ovarian reserve measured by serum AMH level.
METHODOLOGY Retrospective multicentre study based on clinical and blood...